Zucara Therapeutics Announces US$21 Million Series A Financing
Zucara Therapeutics Inc. has announced that it has closed a US$21 million Series A Financing led by Perceptive Xontogeny Venture Fund.
OBIO's COVID-19 Advocacy Efforts
As the health science industry adjusts to the realities of COVID-19, OBIO continues to advocate and work on your behalf. Over the last two weeks, OBIO has engaged with health science companies in a variety of ways.
OBIO Advocating on Behalf of the Health Science Industry
OBIO sends letter to government with recommendations to expand the federal announced wage subsidy
VBI Vaccines Collaborates with NRC to Develop Pan-Coronavirus Vaccine Candidate Targeting COVID-19, SARS and MERS
VBI Vaccines has announced a collaboration with the NRC to develop a pan-coronavirus vaccine candidate, targeting COVID-19, SARS, MERS.
Ontario Government Announces Health Science Industry As Essential Business Sector
The Government of Ontario has announced that the health science industry is deemed an essential service in Ontario and will be exempted from temporary closures of businesses due to COVID-19.
Federal Government Announces New Supports for Business in Fight Against COVID-19
Today, the Government of Canada announced a plan to mobilize industry to combat COVID-19. The plan will redirect a variety of streams of government funding toward manufacturing, commercialization and research focused on health science products and services needed during the pandemic.
Federal Government: Economic Response Plan
The Government of Canada has announced a series of measures to help businesses as they respond to COVID-19.
Update from OBIO
Update from the President and CEO - OBIO’s response to COVID-19
CoHealth Part of RBC Healthcare's Practice Solutions
RBC Healthcare has partnered with four health care tech companies, including CoHealth, on a new package of services to help physicians establish and manage their practices.
Cyclica and ProteinQure Included on Most Promising AI Companies List
CB Insights recently released its annual list of most promising AI start-ups in the world. This year’s list included health care companies Cyclica and ProteinQure.
OBIO launches first Early Adopter Health Network in Ontario
The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization in Ontario, announce today’s launch of the province’s first-of-its-kind Early Adopter Health Network (EAHN). The EAHN is a network of health organizations that get leading-edge technologies into the health system.
ToeFX receives Health Canada approval for clinical trial
ToeFX will begin clinical trials of its light therapy to treat onychomycosis, a fungal infection of the nail.
AMGEN BIONATION Regenerative Medicine Innovation Challenge
AMGEN BIONATION Regenerative Medicine Innovation Challenge 2020 Announces Call for Applications
Conavi Medical Receives Approval from Japan for Instravascular Imaging System
Conavi Medical Inc. has received regulatory approval from the Japanese health ministry for its Novasight Hybrid™ intravascular imaging system.
Reviewing the 2020 Niagara Investment Summit – A Very Canadian Ending
Reviewing the 2020 Niagara Investment Summit – Day 2: A Fireside Chat with David Skok
H2BB Training Days Have Begun
Last week OBIO hosted our newest H2BB trainees for the introductory sessions of our Innovation & Commercialization and Project Management training modules.